The Biotech Growth Trust PLC (BIOG) — Strategic Asset Allocation Index
The Biotech Growth Trust PLC (BIOG) has a Strategic Asset Allocation Index of 109.3% as of September 2025. Strategic assets (PP&E of GBX- plus long-term investments of GBX281.77 Million) total GBX281.77 Million, measured against net assets of GBX257.88 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is The Biotech Growth Trust PLC's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
The Biotech Growth Trust PLC Strategic Asset Allocation Index (2015–2025)
This chart shows how The Biotech Growth Trust PLC's Strategic Asset Allocation Index has evolved across 11 annual periods from 2015 to 2025. As of September 2025, the index stands at 109.3%, representing strategic assets of GBX281.77 Million against net assets of GBX257.88 Million GBX. For live market cap and overall valuation, see The Biotech Growth Trust PLC (BIOG) total market value.
Annual Strategic Asset Allocation Index for The Biotech Growth Trust PLC (2015–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for The Biotech Growth Trust PLC from 2015 to 2025, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See The Biotech Growth Trust PLC book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 98.6% | GBX218.16 Million | GBX- | GBX218.16 Million | GBX221.21 Million | ▼ -10.6 pp |
| 2024 | 109.3% | GBX394.75 Million | GBX- | GBX394.75 Million | GBX361.31 Million | ▲ +1.1 pp |
| 2023 | 108.2% | GBX357.23 Million | GBX- | GBX357.23 Million | GBX330.29 Million | ▼ -0.3 pp |
| 2022 | 108.4% | GBX427.40 Million | GBX- | GBX427.40 Million | GBX394.21 Million | ▲ +1.5 pp |
| 2021 | 107.0% | GBX643.27 Million | GBX- | GBX643.27 Million | GBX601.47 Million | ▼ -2.1 pp |
| 2020 | 109.0% | GBX398.66 Million | GBX- | GBX398.66 Million | GBX365.57 Million | ▲ +3.6 pp |
| 2019 | 105.5% | GBX431.17 Million | GBX- | GBX431.17 Million | GBX408.88 Million | ▼ -1.3 pp |
| 2018 | 106.8% | GBX445.67 Million | GBX- | GBX445.67 Million | GBX417.40 Million | ▲ +3.9 pp |
| 2017 | 102.9% | GBX461.38 Million | GBX- | GBX461.38 Million | GBX448.41 Million | ▼ -8.2 pp |
| 2016 | 111.1% | GBX420.43 Million | GBX- | GBX420.43 Million | GBX378.57 Million | ▲ +1.7 pp |
| 2015 | 109.4% | GBX583.21 Million | GBX- | GBX583.21 Million | GBX533.30 Million | — |